Skip to main content

Table 1 Antenatal and delivery characteristics

From: Prognosis and long-term neurodevelopmental outcome in conservatively treated twin-to-twin transfusion syndrome

Pregnancies(n)

21

Age (years)

28 (20-38)

Parity

0 (0-3)

Gestational age at diagnosis(weeks)

24 (18-34)

Gestational age at delivery(weeks)

28 (22-34)

Diagnosis to delivery interval(days)

25 (1-73)

Use of amnioreduction

13 (61.9%)

Amnioreduction per pregnancy

2.7 (1-6)

Cesarean section

13 (61.9%)

Gestational age < 30 weeks at delivery

15 (71.4%)

Quintero stage I

11 (52.4%)

Quintero stage II

4 (19%)

Quintero stage III

3 (14.3%)

Quintero stage IV

3 (14.3%)

Quintero stage V

0

IUFD of 1 twin

3 (14.3%)

IUFD of both twins

1 (4.8%)

0 survivor*

8 (38.1%)

1 survivor

4 (19%)

2 survivors

9 (42.9%)

Fetus(n)

42

Intrauterine fetal death (IUFD)

5 (11.9%)

Neonatal death

13 (35.1%)

Overall perinatal mortality

18 (42.9%)

Infant death

2 (5.4%)

Lost to follow-up

2 (5.4%)

Long-term survivors

20 (54.1%)

neurodevelopmental impairment

6 (30%)

  1. Data shown as mean (range) or n (%) as appropriate.
  2. *Survivor is defined as the survival of at least 12 months of age.